M. Stokkel

PET/CT with 18F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease.

P. Elkhuizen, B. Koolen, V. Noort, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Toward omitting sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with clinically node-negative breast cancer.

E. van Werkhoven, P. Elkhuizen, G. Sonke, 2020, The British journal of surgery.

[Utility of SPECT/CT scan for anatomical localization of pararectal and presacral sentinel nodes in prostate cancer].

G. Kleinjan, N. S. Berg, J. D. Freitas, 2015, Revista espanola de medicina nuclear e imagen molecular.

The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III–IV BRAF-Mutated Melanoma Patients Treated With Targeted Therapy—What Can Be Learned From Progression?

G. Hospers, J. Haanen, J. D. de Groot, 2023, Clinical nuclear medicine.